help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ives Aguilera, N. S.
Right arrow Articles by Taubenberger, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ives Aguilera, N. S.
Right arrow Articles by Taubenberger, J. K.
(American Journal of Pathology. 1998;153:1969-1976.)
© 1998 American Society for Investigative Pathology


Regular Articles

Differential Expression of Cyclin D1 in Mantle Cell Lymphoma and Other Non-Hodgkin's Lymphomas

Nadine S. Ives Aguilera* , Karen E. Bijwaard{dagger} , Beverly Duncan{dagger} , Amy E. Krafft{dagger} , Wei-Sing Chu* , Susan L. Abbondanzo* , Jack H. Lichy{dagger} and Jeffery K. Taubenberger{dagger}

From the Department of Hematologic and Lymphatic Pathology* and Division of Molecular Pathology,{dagger} Department of Cellular Pathology, Armed Forces Institute of Pathology, Washington DC

Mantle-cell lymphomas are associated with a characteristic chromosomal translocation, t(11;14)(q13;q32). This translocation involves rearrangement of the bcl-1 proto-oncogene from chromosome 11 to the immunoglobulin heavy chain gene on chromosome 14, resulting in an overexpression of cyclin D1 mRNA (also known as bcl-1 and PRAD1). In the current study performed on paraffin-embedded tissue, cyclin D1 mRNA could be detected in 23 of 24 mantle-cell lymphomas by reverse transcription polymerase chain reaction (RT-PCR) whereas only 9 of 24 demonstrated a t(11;14) by PCR. However, we also found that cyclin D1 mRNA could be detected in the majority (11 of 17, 65%) of non-mantle-cell lymphomas and in a minority of atypical lymphoid hyperplasias (3 of 7, 43%). Cyclin D1 mRNA expression was not observed in floridly reactive lymph nodes (0 of 9) or in unstimulated lymph nodes (0 of 20), suggesting that it is a sensitive adjunct marker for malignant lymphoproliferative processes, but not specific for mantle-cell lymphoma. A semiquantitative RT-PCR assay was developed that compared the ratio of cyclin D1 to the constitutively expressed gene ß2-microglobulin. Using this assay on a limited number of our specimens, cyclin D1 overexpression in mantle-cell lymphoma could be reliably distinguished from its expression in other non-Hodgkin's lymphomas. This assay for cyclin D1 expression, designed for formalin-fixed, paraffin-embedded tissue, was a very sensitive and specific marker for mantle-cell lymphoma.





This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
C. D. Jones, K. H. Darnell, R. A. Warnke, and J. L. Zehnder
CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma
J. Mol. Diagn., May 1, 2004; 6(2): 84 - 89.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. G. Howe, J. Crouch, D. Cooper, and B. R. Smith
Real-Time Quantitative Reverse Transcription-PCR for Cyclin D1 mRNA in Blood, Marrow, and Tissue Specimens for Diagnosis of Mantle Cell Lymphoma
Clin. Chem., January 1, 2004; 50(1): 80 - 87.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
V. A. Thomazy, R. Luthra, M. O. Uthman, P. J.A. Davies, and L. J. Medeiros
Determination of Cyclin D1 and CD20 mRNA Levels by Real-Time Quantitative RT-PCR from Archival Tissue Sections of Mantle Cell Lymphoma and Other Non-Hodgkin's Lymphomas
J. Mol. Diagn., November 1, 2002; 4(4): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Specht, M. Kremer, U. Muller, S. Dirnhofer, M. Rosemann, H. Hofler, L. Quintanilla-Martinez, and F. Fend
Identification of Cyclin D1 mRNA Overexpression in B-Cell Neoplasias by Real-Time Reverse Transcription-PCR of Microdissected Paraffin Sections
Clin. Cancer Res., September 1, 2002; 8(9): 2902 - 2911.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
K. S. J. Elenitoba-Johnson, S. D. Bohling, S. D. Jenson, Z. Lin, K. A. Monnin, and M. S. Lim
Fluorescence PCR Quantification of Cyclin D1 Expression
J. Mol. Diagn., May 1, 2002; 4(2): 90 - 96.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Falini and D. Y. Mason
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
Blood, January 15, 2002; 99(2): 409 - 426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. S. Meier, A. Rufle, and F. Gudat
Simultaneous Evaluation of T- and B-Cell Clonality, t(11;14) and t(14;18), in a Single Reaction by a Four-Color Multiplex Polymerase Chain Reaction Assay and Automated High-Resolution Fragment Analysis : A Method for the Rapid Molecular Diagnosis of Lymphoproliferative Disorders Applicable to Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissues, Blood, and Bone Marrow Aspirates
Am. J. Pathol., December 1, 2001; 159(6): 2031 - 2043.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Suzuki, K. Takemura, M. Tsutsumi, S. Nakamura, N. Hamajima, and M. Seto
Detection of Cyclin D1 Overexpression by Real-Time Reverse-Transcriptase-Mediated Quantitative Polymerase Chain Reaction for the Diagnosis of Mantle Cell Lymphoma
Am. J. Pathol., August 1, 2001; 159(2): 425 - 429.
[Abstract] [Full Text]


Home page
BloodHome page
S. E. Straus, E. S. Jaffe, J. M. Puck, J. K. Dale, K. B. Elkon, A. Rosen-Wolff, A. M. J. Peters, M. C. Sneller, C. W. Hallahan, J. Wang, et al.
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis
Blood, July 1, 2001; 98(1): 194 - 200.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. E. Bijwaard, N. S.I. Aguilera, Y. Monczak, M. Trudel, J. K. Taubenberger, and J. H. Lichy
Quantitative Real-Time Reverse Transcription-PCR Assay for Cyclin D1 Expression: Utility in the Diagnosis of Mantle Cell Lymphoma
Clin. Chem., February 1, 2001; 47(2): 195 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
D. A. Arber
Molecular Diagnostic Approach to Non-Hodgkin's Lymphoma
J. Mol. Diagn., November 1, 2000; 2(4): 178 - 190.
[Full Text]


Home page
Am. J. Pathol.Home page
G. Pruneri, S. Fabris, L. Baldini, N. Carboni, S. Zagano, M. A. Colombi, G. Ciceri, L. Lombardi, M. Rocchi, R. Buffa, et al.
Immunohistochemical Analysis of Cyclin D1 Shows Deregulated Expression in Multiple Myeloma with the t(11;14)
Am. J. Pathol., May 1, 2000; 156(5): 1505 - 1513.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Yatabe, R. Suzuki, K. Tobinai, Y. Matsuno, R. Ichinohasama, M. Okamoto, M. Yamaguchi, J.-i. Tamaru, N. Uike, Y. Hashimoto, et al.
Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma
Blood, April 1, 2000; 95(7): 2253 - 2261.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.